IQVIA Holdings Inc.

IQV ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $10.41B $9.74B $6.88B $5.74B $5.46B $5.10B $4.87B $4.33B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $3.3M $5.8M $5.0M $10.4M $10.0M
SG&A Expense $1.72B $1.62B $1.02B $815.0M $781.0M $860.5M $817.8M $762.3M
Operating Income $741.0M $665.0M $576.0M $646.0M $590.0M $462.3M $396.4M $345.3M
Operating Margin 7.1% 6.8% 8.4% 11.3% 10.8% 9.1% 8.1% 8.0%
Interest Expense $414.0M $346.0M $144.0M $101.0M $101.0M $123.5M $-134.4M $109.1M
Pretax Income $328.0M $294.0M $416.0M $539.0M $501.0M $323.1M $267.4M $184.7M
Income Tax Expense $59.0M $-992.0M $325.0M $159.0M $149.0M $96.0M $93.4M $15.1M
Net Income $259.0M $1.28B $72.0M $387.0M $357.0M $226.6M $177.5M $241.8M
Net Margin 2.5% 13.1% 1.0% 6.7% 6.5% 4.4% 3.6% 5.6%
EPS (Basic) $1.27 $5.86 $0.48 $3.15 $2.78 $1.83 $1.53 $2.08
EPS (Diluted) $1.24 $5.74 $0.47 $3.08 $2.72 $1.77 $1.51 $2.05
Shares Outstanding (Basic) 203.7M 217.8M 149.1M 123.0M 128.0M 124.1M 115.7M 116.2M
Shares Outstanding (Diluted) 208.2M 222.6M 152.0M 125.6M 131.1M 127.9M 117.8M 117.9M
Dividends Per Share
← Newer Page 2 of 3 Older →